Duration of Ross River viraemia in a mouse model - implications for transfusion transmission

Vox Sanguinis

Volumn 102, Issue 3, 2012, Pages 185-192

  Shang, G ^a   Seed, C R ^b   Gahan, M E ^a   Rolph, M S ^c   Mahalingam, S ^c  

^a UNIVERSITY OF CANBERRA   (Australia)

^b AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Risk estimation; Ross River virus; Viraemia duration

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE DURATION; INFECTION RISK; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; ROSS RIVER ALPHA VIRUS; ROSS RIVER VIRUS INFECTION; TOGAVIRUS INFECTION; VIREMIA; VIRUS TRANSMISSION;

ADULT; ALPHAVIRUS INFECTIONS; ANIMALS; AUSTRALIA; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HUMANS; MICE; RISK FACTORS; ROSS RIVER VIRUS; TIME FACTORS; VIREMIA;

EID: 84858294815     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01536.x     Document Type: Article

References (34)

1. Harley D, Sleigh A, Ritchie S: Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev 2001; 14:909
2. Aaskov J, Chen J, Hanh N, etal.: Surveillance for Ross River virus infection using blood donors. Am J Trop Med Hyg 1998; 58:726
3. Barber B, Denholm J, Spelman D: Ross River virus. Aust Fam Physician 2009; 38:586-589
4. Holzer GW, Coulibaly S, Aichinger G, et al.: Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection. Vaccine 2011; 29:4132-4141
5. Morrison T, Whitmore A, Shabman R, et al.: Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 2006; 80:737
6. Suhrbier A, La Lin M: Clinical and pathologic aspects of arthritis due to Ross River virus and other alphavirus. Curr Opin Rheumatol 2004; 16:374-379
7. Morrison T, Fraser R, Smith P, etal.: Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J Virol 2007; 81:5132
8. Suhrbier A, Mahalingam S: The immunobiology of viral arthritides. Pharmacol Ther 2009; 124:301-308
9. Rulli N, Melton J, Wilms A, etal.: The molecular and cellular aspects of arthritis due to alphavirus infections. Ann N Y Acad Sci 2007; 1102:96-108
10. Lidbury B, Simeonovic C, Maxwell G, etal.: Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis 2000; 181:27-34
11. Dunstan R, Seed C, Keller A: Emerging viral threats to the Australian blood supply. Aust N Z J Public Health 2008; 32:354-360
12. Weinstein P, Weinstein W, Rowe R: Transfusions: how many cases of Ross River virus infection do we cause? Med J Aust 1995; 163:276
13. Chuang V, Wong T, Leung Y, etal.: Review of dengue fever cases in Hong Kong during 1998 to 2005. Hong Kong Med J 2008; 14:170
14. Tambyah P, Koay E, Poon M, etal.: Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008; 359:1526-1527
15. Seed C, Kiely P, Hyland C, etal.: The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia. Transfusion 2009; 49:1482-1487
16. Biggerstaff BJ, Petersen LR: Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2003; 43:1019-1026
17. Brouard C, Bernillon P, Quatresous I, etal.: Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion 2008; 48:1333-1341
18. Aaskov J, Nair K, Lawrence G, etal.: Evidence for transplacental transmission of Ross River virus in humans. Med J Aust 1981; 2:20
19. Rulli N, Guglielmotti A, Mangano G, etal.: Amelioration of alphavirus induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis Rheum 2009; 60:2513-2523
20. Kuhn RJ, Niesters HGM, Hong Z, etal.: Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology 1991; 182:430-441
21. Rice M, O'Brien S: Genetic variance of laboratory outbred Swiss mice. Nature 1980; 283:157-161
22. Donation eligibility criteria [Monograph on the internet]. Australian Red Cross Blood Service 2011. Available from Accessed on 04/07/2011
23. Shabman RS, Rogers KM, Heise MT: Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells. J Virol 2008; 82:12374
24. Russell R, Cope S, Yund A, etal.: Combatting the enemy - mosquitoes and Ross River virus in a joint military exercise in tropical Australia. Am J Trop Med Hyg 1998; 39:S307
25. Queensland Government: Population and Housing Fact Sheet. Department of Infrastructure and Planning. 2008
26. Calisher C, Monath T: Togaviridae and Flaviviridae: The alphaviruses and flaviviruses; in Lennette EH, Halonen P, Murph FA (eds:) Laboratory Diagnosis of Infectious Disease, Principles and Practice. Volume II, Viral, Rickettsial and Chlamydial Disease. New York, Springer-Verlag, 1988:414
27. Carter I, Smythe L, Fraser R, etal.: Detection of Ross River virus immunoglobulin M antibodies by enzyme-linked immunosorbent assay using antibody class capture and comparison with other methods. Pathology 1985; 17:503-508
28. Hoff J: Technique methods of blood collection in the mouse. Lab Anim (NY) 2000; 29:47-54
29. Sellner L, Coelen R, Mackenzie J: Detection of Ross River virus in clinical samples using a nested reverse trans cription-polymerase chain reaction. Clin Diagn Virol 1995; 4:257-267
30. Stramer S, Glynn S, Kleinman S, etal.: Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351:760
31. Coste J, Reesink H, Engelfriet C, etal.: Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang 2005; 88:289
32. Bae H, Nitsche A, Teichmann A, etal.: Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods 2003; 110:185-191
33. Perkins S, Webb DL, Torrance SA, etal.: Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus. J Clin Microbiol 2005; 43:2356
34. Dodd R, Kurt Roth W, Ashford P, etal.: Transfusion medicine and safety. Biologicals 2009; 37:62-70